Plastic and Reconstructive Surgery, Global Open (Oct 2021)

The Role of von Willebrand Factor in Microvascular Surgery in Severely Injured Patients

  • René M. Rothweiler, MD, DMD,
  • Marc C. Metzger, MD, DMD, PhD,
  • Barbara Zieger, MD, PhD,
  • Sabine Huber-Schumacher, MD,
  • Rainer Schmelzeisen, MD, DMD, PhD,
  • Johannes Kalbhenn, MD, PhD

DOI
https://doi.org/10.1097/GOX.0000000000003836
Journal volume & issue
Vol. 9, no. 10
p. e3836

Abstract

Read online

Summary:. Microvascular anastomosis has become a standard surgical technique for reconstruction because of increasing possibilities, indications, and clinical success regarding the survival of the flaps. However, the main dreaded complications exist in thrombosis. Leaving surgical complications aside, systemic problems like disorder of the coagulation-fibrinolysis system are a significant cause of graft loss usually being unrecognized. Reports exist describing a hypercoagulable state with clotting activation and inhibition of fibrinolysis after trauma and delayed surgery considering the secondary homeostasis. In this clinical case, a patient had a large soft tissue defect at the temporal side of the head after severe trauma. After some days of primary stabilization, reconstruction using a free microvascular latissimus dorsi flap was performed. Multiple revisions of the arterial and venous branches had to be performed intraoperatively due to insufficient flap perfusion. After 24 hours, definitive flap loss occurred due to multiple thrombosis in the arterial and venous branches. Postoperative comprehensive coagulation analysis revealed a distinct activation of primary hemostasis with massively increased von Willebrand factor parameters and factor VIII activity as well as acetylsalicylic acid resistance contributing to thrombotic occlusion. In severely injured patients, comprehensive preoperative determination of the coagulation status (especially those of the primary hemostasis) is indispensable before performing free flap reconstruction surgeries to reduce the risk of microvascular flap loss.